Industry: Healthcare
Published Date: July-2024
Format: PPT*, PDF, EXCEL
Delivery Timelines: Contact Sales
Number of Pages: 244
Report ID: PMRREP34618
1. Executive Summary
1.1. Global Viral Sensitizers Market Snapshot, 2024 and 2031
1.2. Market Opportunity Assessment, 2024 - 2031, US$ Mn
1.3. Key Market Trends
1.4. Future Market Projections
1.5. Premium Market Insights
1.6. Industry Developments and Key Market Events
1.7. PMR Analysis and Recommendations
2. Market Overview
2.1. Market Scope and Definition
2.2. Market Dynamics
2.2.1. Drivers
2.2.2. Restraints
2.2.3. Opportunity
2.2.4. Challenges
2.2.5. Key Trends
2.3. Macro-Economic Factors
2.3.1. Global Sectorial Outlook
2.3.2. Global GDP Growth Outlook
2.3.3. Global Healthcare Spending Outlook
2.4. COVID-19 Impact Analysis
2.5. Forecast Factors - Relevance and Impact
3. Value Added Insights
3.1. Regulatory Landscape
3.2. Product Adoption Analysis
3.3. Value Chain Analysis
3.4. Key Deals and Mergers
3.5. PESTLE Analysis
3.6. Porter's Five Force Analysis
4. Global Viral Sensitizers Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
4.1. Key Highlights
4.1.1. Market Size (US$ Mn) and Y-o-Y Growth
4.1.2. Absolute $ Opportunity
4.2. Market Size (US$ Mn) Analysis and Forecast
4.2.1. Historical Market Size (US$ Mn) Analysis, 2018-2022
4.2.2. Current Market Size (US$ Mn) Analysis and Forecast, 2023-2031
4.3. Global Viral Sensitizers Market Outlook: Application
4.3.1. Introduction / Key Findings
4.3.2. Historical Market Size (US$ Mn) Analysis, By Application, 2018 - 2022
4.3.3. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031
4.3.3.1. Antiviral Drug Development
4.3.3.2. Vaccine Development
4.3.3.3. Oncolytic Viral Therapies
4.3.3.4. Others
4.4. Market Attractiveness Analysis: Application
4.5. Global Viral Sensitizers Market Outlook: End User
4.5.1. Introduction / Key Findings
4.5.2. Historical Market Size (US$ Mn) Analysis, By End User, 2018 - 2022
4.5.3. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
4.5.3.1. Pharmaceutical Companies
4.5.3.2. Research Institutes
4.5.3.3. Biotechnology Companies
4.5.3.4. Others
4.6. Market Attractiveness Analysis: End User
5. Global Viral Sensitizers Market Outlook: Region
5.1. Key Highlights
5.2. Historical Market Size (US$ Mn) Analysis, By Region, 2018 - 2022
5.3. Current Market Size (US$ Mn) Analysis and Forecast, By Region, 2023 - 2031
5.3.1. North America
5.3.2. Europe
5.3.3. East Asia
5.3.4. South Asia and Oceania
5.3.5. Latin America
5.3.6. Middle East & Africa
5.4. Market Attractiveness Analysis: Region
6. North America Viral Sensitizers Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
6.1. Key Highlights
6.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
6.2.1. By Country
6.2.2. By Application
6.2.3. By End User
6.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
6.3.1. U.S.
6.3.2. Canada
6.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031
6.4.1. Antiviral Drug Development
6.4.2. Vaccine Development
6.4.3. Oncolytic Viral Therapies
6.4.4. Others
6.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
6.5.1. Pharmaceutical Companies
6.5.2. Research Institutes
6.5.3. Biotechnology Companies
6.5.4. Others
6.6. Market Attractiveness Analysis
7. Europe Viral Sensitizers Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
7.1. Key Highlights
7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
7.2.1. By Country
7.2.2. By Application
7.2.3. By End User
7.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
7.3.1. Germany
7.3.2. France
7.3.3. U.K.
7.3.4. Italy
7.3.5. Spain
7.3.6. Russia
7.3.7. Türkiye
7.3.8. Rest of Europe
7.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031
7.4.1. Antiviral Drug Development
7.4.2. Vaccine Development
7.4.3. Oncolytic Viral Therapies
7.4.4. Others
7.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
7.5.1. Pharmaceutical Companies
7.5.2. Research Institutes
7.5.3. Biotechnology Companies
7.5.4. Others
7.6. Market Attractiveness Analysis
8. East Asia Viral Sensitizers Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
8.1. Key Highlights
8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
8.2.1. By Country
8.2.2. By Application
8.2.3. By End User
8.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
8.3.1. China
8.3.2. Japan
8.3.3. South Korea
8.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031
8.4.1. Antiviral Drug Development
8.4.2. Vaccine Development
8.4.3. Oncolytic Viral Therapies
8.4.4. Others
8.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
8.5.1. Pharmaceutical Companies
8.5.2. Research Institutes
8.5.3. Biotechnology Companies
8.5.4. Others
8.6. Market Attractiveness Analysis
9. South Asia & Oceania Viral Sensitizers Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
9.1. Key Highlights
9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
9.2.1. By Country
9.2.2. By Application
9.2.3. By End User
9.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
9.3.1. India
9.3.2. Southeast Asia
9.3.3. ANZ
9.3.4. Rest of South Asia & Oceania
9.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031
9.4.1. Antiviral Drug Development
9.4.2. Vaccine Development
9.4.3. Oncolytic Viral Therapies
9.4.4. Others
9.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
9.5.1. Pharmaceutical Companies
9.5.2. Research Institutes
9.5.3. Biotechnology Companies
9.5.4. Others
9.6. Market Attractiveness Analysis
10. Latin America Viral Sensitizers Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
10.1. Key Highlights
10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
10.2.1. By Country
10.2.2. By Application
10.2.3. By End User
10.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
10.3.1. Brazil
10.3.2. Mexico
10.3.3. Rest of Latin America
10.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031
10.4.1. Antiviral Drug Development
10.4.2. Vaccine Development
10.4.3. Oncolytic Viral Therapies
10.4.4. Others
10.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
10.5.1. Pharmaceutical Companies
10.5.2. Research Institutes
10.5.3. Biotechnology Companies
10.5.4. Others
10.6. Market Attractiveness Analysis
11. Middle East & Africa Viral Sensitizers Market Outlook: Historical (2018 - 2023) and Forecast (2024 - 2031)
11.1. Key Highlights
11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2018 - 2022
11.2.1. By Country
11.2.2. By Application
11.2.3. By End User
11.3. Current Market Size (US$ Mn) Analysis and Forecast, By Country, 2023 - 2031
11.3.1. GCC Countries
11.3.2. Egypt
11.3.3. South Africa
11.3.4. Northern Africa
11.3.5. Rest of Middle East & Africa
11.4. Current Market Size (US$ Mn) Analysis and Forecast, By Application, 2023 - 2031
11.4.1. Antiviral Drug Development
11.4.2. Vaccine Development
11.4.3. Oncolytic Viral Therapies
11.4.4. Others
11.5. Current Market Size (US$ Mn) Analysis and Forecast, By End User, 2023 - 2031
11.5.1. Pharmaceutical Companies
11.5.2. Research Institutes
11.5.3. Biotechnology Companies
11.5.4. Others
11.6. Market Attractiveness Analysis
12. Competition Landscape
12.1. Market Share Analysis, 2023
12.2. Market Structure
12.2.1. Competition Intensity Mapping By Market
12.2.2. Competition Dashboard
12.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
12.3.1. Thermo Fisher Scientific
12.3.1.1. Overview
12.3.1.2. Segments and Products
12.3.1.3. Key Financials
12.3.1.4. Market Developments
12.3.1.5. Market Strategy
12.3.2. FUJIFILM Irvine Scientific
12.3.2.1. Overview
12.3.2.2. Segments and Products
12.3.2.3. Key Financials
12.3.2.4. Market Developments
12.3.2.5. Market Strategy
12.3.3. Virica Biotech
12.3.3.1. Overview
12.3.3.2. Segments and Products
12.3.3.3. Key Financials
12.3.3.4. Market Developments
12.3.3.5. Market Strategy
12.3.4. Tocris Bioscience
12.3.4.1. Overview
12.3.4.2. Segments and Products
12.3.4.3. Key Financials
12.3.4.4. Market Developments
12.3.4.5. Market Strategy
12.3.5. Takara Bio Inc.
12.3.5.1. Overview
12.3.5.2. Segments and Products
12.3.5.3. Key Financials
12.3.5.4. Market Developments
12.3.5.5. Market Strategy
12.3.6. ALSTEM
12.3.6.1. Overview
12.3.6.2. Segments and Products
12.3.6.3. Key Financials
12.3.6.4. Market Developments
12.3.6.5. Market Strategy
12.3.7. UniProt
12.3.7.1. Overview
12.3.7.2. Segments and Products
12.3.7.3. Key Financials
12.3.7.4. Market Developments
12.3.7.5. Market Strategy
12.3.8. OZ Biosciences
12.3.8.1. Overview
12.3.8.2. Segments and Products
12.3.8.3. Key Financials
12.3.8.4. Market Developments
12.3.8.5. Market Strategy
12.3.9. Applied Biological Materials
12.3.9.1. Overview
12.3.9.2. Segments and Products
12.3.9.3. Key Financials
12.3.9.4. Market Developments
12.3.9.5. Market Strategy
12.3.10. Virongy Biosciences
12.3.10.1. Overview
12.3.10.2. Segments and Products
12.3.10.3. Key Financials
12.3.10.4. Market Developments
12.3.10.5. Market Strategy
12.3.11. Miltenyi Biotech
12.3.11.1. Overview
12.3.11.2. Segments and Products
12.3.11.3. Key Financials
12.3.11.4. Market Developments
12.3.11.5. Market Strategy
12.3.12. SIRION Biotech
12.3.12.1. Overview
12.3.12.2. Segments and Products
12.3.12.3. Key Financials
12.3.12.4. Market Developments
12.3.12.5. Market Strategy
12.3.13. Boca Scientific
12.3.13.1. Overview
12.3.13.2. Segments and Products
12.3.13.3. Key Financials
12.3.13.4. Market Developments
12.3.13.5. Market Strategy
12.3.14. System Biosciences
12.3.14.1. Overview
12.3.14.2. Segments and Products
12.3.14.3. Key Financials
12.3.14.4. Market Developments
12.3.14.5. Market Strategy
13. Appendix
13.1. Research Methodology
13.2. Research Assumptions
13.3. Acronyms and Abbreviations
Report Sample is Available
In-depth report coverage is now just a few seconds away
Get FREE Report Sample
Make This Report Your Own
Take Advantage of Intelligence Tailored to your Business Objective
Get a Customized Version
